Clinical and Pathological Factors Related to 18F-FDG-PET Positivity in the Diagnosis of Recurrence and/or Metastasis in Patients with Differentiated Thyroid Cancer |
| |
| Authors: | D Esteva MD M A Muros PhD J M Llamas-Elvira PhD J Jiménez Alonso PhD J M Villar PhD M López de la Torre PhD T Muros PhD |
| |
| Institution: | (1) Internal Medicine Department, Virgen de las Nieves University Hospital, Granada, Spain;(2) Nuclear Medicine Department, Virgen de las Nieves University Hospital, Granada, Spain;(3) Endocrine Surgery Unit, General and Digestive Surgery Department, Virgen de las Nieves University Hospital, Granada, Spain;(4) Endocrinology Department, Virgen de las Nieves University Hospital, Granada, Spain |
| |
| Abstract: | Background Objectives were to analyze the relationship between a positive 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) result and clinical and tumor factors in patients treated for
differentiated thyroid cancer (DTC) and under suspicion of recurrence or metastasis, and to determine the diagnostic validity
of PET in DTC patients with elevated serum thyroglobulin (Tg) and negative 131I whole-body scan (131I-WBS).
Methods We studied 50 DTC patients with elevated serum Tg and negative WBS treated with total thyroidectomy and 131I ablation. Thyroxin treatment was withdrawn and patients were on iodine-free diet before WBS. Tg, anti-Tg antibodies, and
thyroid-stimulating hormone (TSH) were determined. Patients with negative WBS and elevated Tg underwent PET study 1 week later.
PET findings were verified by pathology findings or other imaging techniques computed tomography (CT), magnetic resonance
imaging (MRI), ultrasound (US)] and/or 12-month follow-up. The relationship between PET findings and tumor (histological type,
size, multifocality, thyroid capsular invasion, lymph-node and/or metastatic involvement) and clinical (age at diagnosis,
sex, Tg, accumulated iodine dose, and recurrence time) variables was analyzed.
Results PET was positive in 32/39 patients with confirmed disease (82% sensitivity) and negative in 7/11 of disease-free cases (64%
specificity), a positive predictive value (PPV) of 89%. Tumor size (P < 0.05) and thyroid capsular invasion (P < 0.05) were significantly associated with positive PET study. The relationship of PET findings with Tg levels and age at
diagnosis was close to significance.
Conclusion
18F-FDG-PET study offers a high sensitivity and positive predictive value (PPV) in patients with negative WBS and Tg positive.
The use of FDG-PET is strongly recommended in DTC patients with large tumors, thyroid capsule invasion or poor-prognosis variants. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
